Navigation Links
Statement From the Consumer Healthcare Products Association on the SAMHSA Findings on Cough Medicine Abuse
Date:1/9/2008

WASHINGTON, Jan. 9 /PRNewswire-USNewswire/ --- Following is a statement by Linda A. Suydam, D.P.A., president of the Consumer Healthcare Products Association (CHPA), regarding today's release of the U.S. Health and Human Services Substance Abuse & Mental Health Services Association's National Survey on Drug Use and Health survey, which reported data on the prevalence of over-the-counter (OTC) cough medicine abuse among 12- to 25-year-olds in 2006:

"SAMHSA's annual study provides some valuable insight for parents and healthcare professionals to better understand teen behaviors, and we commend the survey authors for examining the troubling trend of young people abusing medicines to get high. The leading makers of OTC cough medicines are working tirelessly to raise awareness about cough medicine abuse and welcome these data to help inform adults about this dangerous behavior.

"These results --- as well as recent national survey results from the National Institute on Drug Abuse (NIDA)'s Monitoring the Future survey --- are evidence of the importance of the education efforts of many, including CHPA members.

"The nation's medicine makers are committed to providing educational programming about medicine abuse in the schools, at retail, within law enforcement, in the community, and online. And we've worked with lawmakers to advance legislation to prohibit the sale of the raw form of the active ingredient in cough medicines, dextromethorphan, to minors. But our job is far from over.

"CHPA and the makers of over-the-counter cough medicines remain dedicated to building on the successes of our multi-year educational campaign and are looking forward to the new programming 2008 will bring with our partners, including the Community Anti-Drug Coalitions of America, the Parent Teacher Association, the Partnership for a Drug-Free America, D.A.R.E. America, and the online Five Moms campaign.

"Our goal is to make sure parents are awar
'/>"/>

SOURCE Consumer Healthcare Products Association
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Statement of Eli Lilly and Company on Dr. David Egilman Settlement:
2. Takeda statement on ACTOS meta-analysis published in the Journal of the American Medical Association
3. Takeda Statement on ACTOS(R) (Pioglitazone HCl) Meta-Analysis Published in the Journal of the American Medical Association
4. Statement by Mike Leavitt Secretary of Health and Human Services on the United States-China Bilateral Meetings on Food and Drug Safety
5. Statement by Oscar S. Wyatt, Jr.
6. Statement from Employment Policies Institute on Senator Hillary Clintons Health Care Plan
7. Pelosi Statement on Proposed Entitlement Task Force
8. Statement by Robert Greenstein, Executive Director of the Center on Budget and Policy Priorities, on the New Congressional SCHIP Agreement
9. Statement on House/Senate Agreement on SCHIP Legislation
10. Statement from the Alliance for Quality Nursing Home Care
11. Produce for Better Health Foundation Releases Statement on Study Saying Fruit & Vegetable Consumption Not Strongly Associated With Colon Cancer Risk

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...Call/ - AIM Health Group Inc. ("AIM" or the "Compa...company, announced today that its net income for t...e "Quarter") increased to $633,199 from $12,319 in...1) increased 290% to $910,734 from $230,862, on a ...nced that revenues increased 87% to $13.1 million ...
(Date:11/30/2009)...act, CBO analysis understates the effect ,, WA... Blue Cross and Blue Shield Association (BCBSA) is...e released today by the Congressional Budget Offic...conomists, actuaries, and health policy experts ha...ll would make coverage more expensive for millions...
(Date:11/30/2009)...than sedentary, healthy adults , , , MO...wn that exercise can help ward off heart disease a...son why may be found within cells themselves. , ...at the tips of chromosomes that protect the cell -...ing adults who did not exercise regularly, German ...
(Date:11/30/2009)...swire-FirstCall/ -- Jedi Mind, Inc . (Pink Sheets...ce the Company,s first thought-controlled game is ...ink-Tac-Toe" is the first of its kind, which allow...r mind and is geared towards people of all ages. T...can be purchased directly through the Company by c...
(Date:11/30/2009)...re/ -- Of the more than one million people in the ... half are African American. Moreover, the HIV/AIDS...d the threshold for a severe epidemic three times ...ent of all women infected with the virus in the na....*, World AIDS Day, BET shines a light on these al...
Breaking Medicine News(10 mins):Health News:AIM Health Group Inc. continues increased quarterly profits 2Health News:AIM Health Group Inc. continues increased quarterly profits 3Health News:AIM Health Group Inc. continues increased quarterly profits 4Health News:CBO Confirms That Premiums Will Increase Under the Senate Healthcare Reform Bill 2Health News:Exercise Guards White Blood Cells Against Aging 2Health News:Exercise Guards White Blood Cells Against Aging 3Health News:First Thought-Controlled Game Complete From Jedi Mind, Inc. 2Health News:BET Networks Joins the International Call to Stop the Spread of HIV on World Aids Day Tuesday, December 1 with an Annual Special Episode of '106 & PARK' and on the Ground Initiatives Through BET's Award Winning Public Affairs Campaign Rap-It-Up 2Health News:BET Networks Joins the International Call to Stop the Spread of HIV on World Aids Day Tuesday, December 1 with an Annual Special Episode of '106 & PARK' and on the Ground Initiatives Through BET's Award Winning Public Affairs Campaign Rap-It-Up 3
... A single tumor-suppressing gene is a key to unde...ncer cells that persist after initial treatment on...versity of Texas M. D. Anderson Cancer Center repo...f-cannibalization, in ovarian cancer cells. Often...
...t of its kind study, a first-degree family history... outcomes of prostate cancer patients treated with...tients with this type of family history have clini...tion Oncology*Biology*Physics , the official journ...
...rs at the University Of Southern California, Schoo...at links oral bisphosphonates to increased jaw nec... that even short-term use of common oral osteoporo...ociation ( JADA ). , Osteoporosis currently affe...
... MD (Jan. 1, 2009) Antioxidant supplementation wa...cing levels of oxidative stress in patients with c...Gastroenterology . CP is a progressive inflammator...r problem in 90 percent of patients with CP and cu...
...Mass.Everybody is familiar with the stereotypes of...rueling hours, little recognition, and even less g...demic Medicine this month pulls back the curtain ... raises questions about how the prevailing culture...
...t lead to new treatment for blood cancers, researc... News) -- More than three-quarters of laboratory l...ds died within 24 hours, effectively killing thems...tein that regulates the cell-signaling pathway the...
Other Medicine News:Health News:Dormant cancer cells rely on cellular self-cannibalization to survive 2Health News:Family history of prostate cancer does not affect some treatment outcomes 2Health News:USC dentist links Fosomax-type drugs to jaw necrosis 2Health News:Antioxidants offer pain relief in patients with chronic pancreatitis 2Health News:The culture of medicine 2Health News:Grape Seed Extract Kills Leukemia Cells in Lab 2
(Date:11/30/2009)...LOS, Calif., Nov. 30 Nek...the promotion of Lorianne Masuoka, M.D. to Senior ...uoka will report directly to Nektar,s President an..., "Lorianne,s outstanding leadership and highly ef...instrumental in rapidly advancing Nektar,s proprie...
(Date:11/30/2009)...L, Wash., Nov. 30 SCOLR ...at on November 25, 2009, the NYSE Amex LLC (the "E...d the Company,s plan to comply with its previously...)(iv) of the Exchange Company Guide. Specifically...stained losses which were so substantial in relati...
(Date:11/30/2009)...W YORK, Nov. 30 Reportlinker.com a...lable in its catalogue: ,, Cardiac Defibrillat..., http://www.reportlinker.com/p0164315/Cardiac-De...ort.html ,, Cardiovascular disease (CVD) is o...den cardiac arrest survivors are prone to arrhythm...
Breaking Medicine Technology:Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Senior Vice President and Chief Medical Officer 2Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Senior Vice President and Chief Medical Officer 3SCOLR Pharma, Inc. Receives Notices From NYSE Amex LLC Regarding Compliance Plan and Listing Standards 2SCOLR Pharma, Inc. Receives Notices From NYSE Amex LLC Regarding Compliance Plan and Listing Standards 3SCOLR Pharma, Inc. Receives Notices From NYSE Amex LLC Regarding Compliance Plan and Listing Standards 4Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 2Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 3Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 4Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 5Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 6Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 7Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 8Early detection of osteoarthritis in dogs could open doors for a cure 48474 1Early detection of osteoarthritis in dogs could open doors for a cure 48474 2Legislation Will Expand Access to Life Saving Laboratory Tests 48470 1Legislation Will Expand Access to Life Saving Laboratory Tests 48470 2Beetle shell inspires brilliant white paper 8787 1Beetle shell inspires brilliant white paper 8787 2Beetle shell inspires brilliant white paper 8787 3
... Immunosyn,Corporation (OTC Bulletin Board: IMYN) ...dies Summary (CFR 312.36). The Institute of Biolo...logies, LLC, Immunosyn,s largest shareholder, to c...1019 on several progressive neurological,auto-immu... no satisfactory,form of therapy. The studies were...
...udy highlight significant improvements in RA symp... ACTEMRA that specifically targets int...a from two pivotal,multinational Phase III clinica...ocilizumab) significantly improved the signs and s...failed to adequately respond to,anti-rheumatic the...
Other Medicine Technology:Immunosyn Corporation Releases SF-1019 Study Results 2Immunosyn Corporation Releases SF-1019 Study Results 3Two Pivotal Phase III Studies for Roche's ACTEMRA(TM) (tocilizumab) Demonstrate Significant Improvement in Rheumatoid Arthritis Symptoms 2Two Pivotal Phase III Studies for Roche's ACTEMRA(TM) (tocilizumab) Demonstrate Significant Improvement in Rheumatoid Arthritis Symptoms 3Two Pivotal Phase III Studies for Roche's ACTEMRA(TM) (tocilizumab) Demonstrate Significant Improvement in Rheumatoid Arthritis Symptoms 4Two Pivotal Phase III Studies for Roche's ACTEMRA(TM) (tocilizumab) Demonstrate Significant Improvement in Rheumatoid Arthritis Symptoms 5Two Pivotal Phase III Studies for Roche's ACTEMRA(TM) (tocilizumab) Demonstrate Significant Improvement in Rheumatoid Arthritis Symptoms 6
Immersion Oil, 21,000 cs
Immersion Oil, 1,250 cs
...andard - the ones to compare with, the ones to com...ly led in the development and standardization of i...: , When the FDA set general purpose reagent ...nostics in the 1970's, Cargille Immersion Oils wer...
...tube system for screening of stool specimens for S...de; is specifically designed to rule out normal en...fferentiation of Salmonella and Shigella species. ...n Agar (LIA), and Urea Agar, are used to screen no...
Medicine Products: